Gluskin Sheff + Associates (TSE:GS) had its price objective lowered by stock analysts at Desjardins from C$12.50 to C$12.00 in a report released on Monday, February 4th. The firm currently has a “buy” rating on the stock. Desjardins’ price target would suggest a potential upside of 5.63% from the stock’s current price. Desjardins also issued estimates for Gluskin Sheff + Associates’ Q2 2019 earnings at $0.20 EPS, FY2019 earnings at $0.88 EPS and FY2020 earnings at $1.30 EPS.
A number of other equities research analysts have also issued reports on GS. Royal Bank of Canada cut their target price on Gluskin Sheff + Associates from C$18.00 to C$15.00 and set a “sector perform” rating on the stock in a research report on Thursday, October 18th. BMO Capital Markets lowered their price target on Gluskin Sheff + Associates from C$16.00 to C$14.00 in a report on Thursday, October 18th. TD Securities lowered their target price on Gluskin Sheff + Associates from C$16.00 to C$13.00 and set a “hold” rating on the stock in a research note on Friday, October 19th. Finally, CIBC cut their price objective on Gluskin Sheff + Associates from C$15.00 to C$13.00 in a research report on Friday, November 16th.
Shares of GS traded up C$0.14 during midday trading on Monday, reaching C$11.36. The stock had a trading volume of 117,900 shares, compared to its average volume of 258,887. Gluskin Sheff + Associates has a 52 week low of C$9.07 and a 52 week high of C$18.05. The company has a market capitalization of $342.54 million and a PE ratio of 12.61.
About Gluskin Sheff + Associates
Gluskin Sheff + Associates Inc is a publicly owned investment manager. The firm also provides wealth management services. It primarily provides its services to high net worth investors, including entrepreneurs, professionals, family trusts, private charitable foundations, pension and profit sharing plans, pooled investment vehicles, charitable organizations , corporations, institutions, insurance companies, and estates.
Further Reading: Short Selling – Explanation For Shorting Stocks
Receive News & Ratings for Gluskin Sheff + Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gluskin Sheff + Associates and related companies with MarketBeat.com's FREE daily email newsletter.